LIVERAL
Phase 1/2 Completed
14 enrolled
LHWAA
Phase NA Completed
232 enrolled
YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)
Phase 2 Completed
62 enrolled
OUTREACH2
Phase 2 Completed
8 enrolled
Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study
Completed
207 enrolled
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
Phase 1 Completed
29 enrolled
Prevention of Recurrent Hepatitis B After Liver Transplantation
Completed
317 enrolled
A Cross Sectional Study Evaluating the Mean Levels of Alpha Fetoprotein in Patients of Hepatocellular Carcinoma and Its Correlates in Pakistan
Completed
94 enrolled
Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
Completed
569 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence
Completed
207 enrolled
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Completed
892 enrolled
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
Completed
3,900 enrolled
Effects of Antiviral Therapy on Patients With HBV-related HCC
Completed
494 enrolled
Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening
Phase NA Completed
178 enrolled
GEHEP-002
Completed
477 enrolled
Community-based Hepatitis B Interventions for Hmong Adults
Phase NA Completed
1,500 enrolled
Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)
Phase 2 Completed
566 enrolled
OPTISCREEN-B
Phase NA Completed
1,000 enrolled 7 charts
OPTISCREEN-III
Phase NA Completed
327 enrolled 9 charts
Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer
Phase NA Completed
200 enrolled
TACEPVE
Phase NA Completed
20 enrolled
HBV/HCC
Completed
306 enrolled
Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma
Phase NA Completed
300 enrolled
Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection
Phase NA Completed
130 enrolled
Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication
Completed
25 enrolled
Qidong Hepatitis B Intervention Study
Phase 4 Completed
80,000 enrolled